FDA Investigator Graeme E Price
Graeme E Price has inspections in 1 countries as of 05 May 2023. Graeme E Price has collaborated with a combinined 773 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
05 May 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Amy M Cramer,
Annemarie Bodnar,
Arie C Menachem,
Atul J Agrawal,
CDR Donald Ertel,
Dan Grabicki,
Daniel J Grabicki,
David E Bailey,
Donald C Obenhuber, PhD,
Emest F Bizjak,
Erik W Koester,
Frederick Razzaghi,
Gene D Arcy,
Graeme Price,
Gregory Price,
Hoda N Abadeer,
Jacqueline Mdiaz Albertini,
Joy Rkozlowski Klena,
Kathleen M Jordan,
Kristy A Zielny,
Kristy E Zuroski,
Laurel A Beer,
Lauren N Barber,
Lily Y Koo,
Megan A Haggerty,
Michael Havert, PhD,
Michael Serrano,
Michael Shanks, MS,
Monica Commerford, PhD,
Nirjal Bhattarai,
Patricia Fhughes Troost,
Paul L Bellamy,
Phillip C Thai,
Robert J Martin,
Scott T Ballard,
Sean R Marcsisin,
Thuy T Nguyen, LCDR,
Tiffany M Lucas,
Viviana R Ramirez,
Wei Wanet,
Wei Wang, PhD,
Zhaohui Ye,
Zhihao Qiu (Peter), PhD,
Zhongren Wu
Graeme E Price's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2017 | FDA 483 Response | KITE PHARMA, INC. - Form 483R, 2017-06-29 |
June, 2017 | EIR | KITE PHARMA, INC. - EIR, 2017-06-16 |
June, 2017 | FDA 483 | KITE PHARMA, INC. - Form 483, 2017-06-16 |
September, 2023 | FDA 483 | Minaris Regenerative Medicine, LLC - Form 483, 2023-09-25 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more